Inside Moderna and Merck’s Cancer Vaccine Breakthrough
In a milestone for medical research, Moderna and Merck & Co. announced that their personalized mRNA cancer vaccine achieved success in a late-stage clinical trial.
In a milestone for medical research, Moderna and Merck & Co. announced that their personalized mRNA cancer vaccine achieved success in a late-stage clinical trial.